Hero Patch Information

Anodyne is a clinical-stage biotech company simplifying chronic care through a breakthrough in drug delivery. Our proprietary platform, the HeroPatch, is a microneedle patch that delivers multi-milligram doses of biologics, peptides, and monoclonal antibodies through the skin, therapies that previously required injection or IV infusion. Built on solid-state, solvent-free fabrication, the HeroPatch delivers drug loads of up to tens of mg per patch with tunable pharmacokinetic profiles. Stable at room temperature, it eliminates cold-chain logistics and reduces cost up to tenfold versus pen injections. The platform also unlocks next-generation combination therapies, with individual release profiles per molecule. Our pipeline spans a portfolio of programs across obesity, metabolic disease, and beyond, advanced through internal clinical development and strategic external partnerships to maximize the clinical impact and commercial potential of the platform. Anodyne is building a future where complex therapies are easier to access, easier to administer, and easier to live with, for patients and every stakeholder in chronic care.